Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET
Company Participants
Scott Wolchko - President and Chief Executive Officer
Wayne Chu - Chief Medical Officer
Ed Dulac - Chief Financial Officer
Bob Valamehr - Chief Research and Development Officer
Conference Call Participants
Carly Kenselaar - Citi
Daina Graybosch - SVB Securities
Tazeen Ahmad - Bank of America
Andrea Tan - Goldman Sachs
Robyn Karnauskas - Truist
Mara Goldstein - Mizuho
Matthew Biegler - Oppenheimer
Operator
Welcome to the Fate Therapeutics Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate’s website at fatetherapeutics.com. As a reminder, today’s call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.
Scott Wolchko
Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics fourth quarter 2022 financial results call. Shortly after 4:00 p.m. Eastern Time today, we issued a press release with these results, which can be found on the Investors section of our website under Press Releases. In addition, our Form 10-K for the year ended December 31, 2022 was filed shortly thereafter and can be found on the Investors section of our website under Financial Information.
Before we begin, I would like to remind everyone that except for statements of historical facts, the statements made by management and responses to questions on this conference call are forward-looking statements under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Please see the forward-looking statement disclaimer on the company’s earnings press release issued after the close of
- Read more current FATE analysis and news
- View all earnings call transcripts